Camlin Fine Sciences

Camlin Fine Sciences

Manufacturer and exporter of bulk drugs. Learn more

Launch date
Employees
Market cap
€220m
Enterprise valuation
€295m (Public information from Sep 2024)
Mumbai Maharashtra (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
INR2020202120222023202420252026
Revenues10.4b11.8b14.1b16.8b16.0b18.8b20.7b
% growth17 %13 %19 %19 %(5 %)18 %10 %
EBITDA1.2b1.9b1.8b2.1b1.2b2.1b2.6b
% EBITDA margin11 %16 %13 %13 %7 %11 %13 %
Profit303m510m607m521m(928m)503m853m
% profit margin3 %4 %4 %3 %(6 %)3 %4 %
EV / revenue0.5x1.5x1.6x1.2x0.9x0.9x0.8x
EV / EBITDA4.1x9.4x12.2x9.5x12.6x8.3x6.6x
  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO

INR1.8b

Post IPO Equity
*

€20.0m

Post IPO Equity
Total Funding-

Recent News about Camlin Fine Sciences

Edit
More about Camlin Fine Sciencesinfo icon
Edit

Camlin Fine Sciences (CFS) operates in the specialty chemicals sector, providing high-quality chemical solutions for various industries. The company serves clients in sectors such as food, pharmaceuticals, petrochemicals, and animal nutrition. CFS operates globally with a significant presence in North America, Europe, and Asia. The business model revolves around manufacturing and supplying specialty chemicals, including antioxidants, aroma chemicals, and performance chemicals. Revenue is generated through long-term supply agreements and joint ventures, such as the partnership with Lockheed Martin for advanced energy storage solutions and a joint venture with Pahang Pharma for animal nutrition. CFS's greenfield expansion in Dahej SEZ and its vertical integration strategy enhance its production capabilities and market reach. The company is also committed to corporate social responsibility, focusing on healthcare, education, and environmental sustainability.

Keywords: specialty chemicals, antioxidants, aroma chemicals, performance chemicals, energy storage, animal nutrition, global presence, joint ventures, vertical integration, sustainability.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Camlin Fine Sciences

Edit
Dresen Quimica S.A de C.V.
ACQUISITION by Camlin Fine Sciences May 2016
Vitafor
ACQUISITION by Camlin Fine Sciences Jun 2024
AlgalR
ACQUISITION by Camlin Fine Sciences May 2021